Valuation AFT Pharmaceuticals Limited

Stocks

End-of-day quote New Zealand S.E. 22/10/2026			5-day change	1st Jan Change
4.590 ^NZD	+0.22%		+4.32%	+35.80%

10-06	ASX Preview: Australian Shares to Rise as Oil Prices Fall; Tower Lifts Fiscal 2026 Profit Guidance	MT
10-06	AFT Pharmaceuticals on Track for Fiscal 2027 Revenue, Profit Targets	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	378	362.8	328.2	282.1	352.4	481.4	-	-
Change	-	-4%	-9.54%	-14.06%	24.91%	36.62%	-	-
Enterprise Value (EV) ¹	407.3	392.7	344.4	296.6	391	511.2	506	501.5
Change	-	-3.57%	-12.3%	-13.89%	31.82%	30.76%	-1.02%	-0.88%
P/E	19x	34.6x	20.9x	24.5x	24x	24.4x	19.4x	18.1x
PBR	6.66x	4.95x	3.74x	2.89x	3.2x	5.26x	4.39x	3.62x
PEG	-	-0.7x	0.4x	-0.9x	0.9x	0.7x	0.7x	2.56x
Capitalization / Revenue	2.9x	2.32x	1.68x	1.36x	1.38x	1.58x	1.39x	1.23x
EV / Revenue	3.13x	2.51x	1.76x	1.43x	1.53x	1.68x	1.47x	1.28x
EV / EBITDA	19x	18.4x	13.1x	14.2x	13.6x	14.8x	12.2x	10x
EV / EBIT	20x	20x	14.2x	16.8x	16x	16.7x	13.7x	11.1x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.016	0.018	0.025	0.0328	0.0416	0.0652
Rate of return	-	-	0.51%	0.67%	0.74%	0.71%	0.91%	1.42%
EPS ²	0.19	0.1	0.15	0.11	0.14	0.1878	0.2366	0.2533
Distribution rate	-	-	10.7%	16.4%	17.9%	17.4%	17.6%	25.7%
Net sales ¹	130.3	156.6	195.4	208	254.7	303.8	345.2	392.5
EBITDA ¹	21.43	21.39	26.25	20.88	28.8	34.63	41.41	49.9
EBIT ¹	20.39	19.67	24.24	17.65	24.44	30.64	37.05	45.17
Net income ¹	19.85	10.65	15.61	11.96	14.73	19.7	24.81	26.56
Net Debt ¹	29.3	29.9	16.2	14.5	38.6	29.84	24.6	20.14
Reference price ²	3.610	3.460	3.130	2.690	3.360	4.590	4.590	4.590
Nbr of stocks (in thousands)	104,697	104,866	104,866	104,866	104,866	104,875	-	-
Announcement Date	5/22/22 A	5/22/23 A	5/22/24 A	5/21/25 A	5/20/26 A	-	-	-

¹NZD in Million²NZD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
AFT PHARMACEUTICALS LIMITED	24.44x	1.68x	14.76x	0.71%	273M
ELI LILLY AND COMPANY	37.7x	13.43x	28.51x	0.52%	1,165B
JOHNSON & JOHNSON	39.17x	6.59x	18.54x	1.99%	645B
ABBVIE INC.	36.4x	8.37x	17.27x	2.41%	504B
ROCHE HOLDING AG	20.97x	5.15x	12.78x	2.55%	380B
MERCK & CO., INC.	107.33x	5.99x	25.72x	2.31%	363B
NOVARTIS AG	21.95x	5.71x	14.04x	2.79%	297B
ASTRAZENECA PLC	22.67x	4.58x	13.09x	1.93%	269B
AMGEN INC.	28.38x	7.14x	12.79x	2.26%	237B
GILEAD SCIENCES, INC.	-45.82x	7.02x	27.23x	2.1%	195B
Average	29.32x	6.57x	18.47x	1.96%	405.58B
Weighted average by Cap.	35.73x	8.44x	20.74x	1.78%